Skip to content
Screener

Sanara MedTech Inc. SMTI Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$26.3MMiss by $866.2K
EPS$0.09Beat by $0.33
Revenue estimate$27.2M
EPS estimate-$0.24

Next report

Nov 11, 2026 (in a month)
Revenue estimate$29.7M
EPS estimate$0.06

Financials

Q3 2025

Income statement

See full
Revenue$26.3M+21.5%
Gross profit$24.5M+24.3%
Operating income$2.9M+278%
Net income-$30.4M-964%
EPS (diluted)-$3.40-900%

Balance sheet

See full
Cash & equivalents$14.9M-8.2%
Total debt$47.4M+48.5%
Total equity$6.1M-84.5%
Total assets$71.1M-19.7%

Cash flow

See full
Operating cash flow$2.2M—
CapEx$1.1M+11,548%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$282.47M+10.3%
Enterprise value$314.92M+15.9%
P/S2.8×-0.5×

Profitability

See full
Gross margin92.2%+2.1pp
Operating margin8.4%+6.1pp
Net margin-36.8%-62.5pp

Returns & leverage

See full
Return on equity-163.2%-190pp
Debt / equity7.7×+6.9×
Current ratio1.8×-0.4×

Segments

By product

See full
Soft Tissue Repair Products$23.4M+24.2%
Bone Fusion Products$2.9M+3.6%

FAQ

When did Sanara MedTech Inc. report Q3 2025 earnings?
Sanara MedTech Inc. (SMTI) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Sanara MedTech Inc.'s Q3 2025 revenue and EPS?
Sanara MedTech Inc. reported revenue of $26.3M and eps of $0.09 for Q3 2025.
Did Sanara MedTech Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $27.2M by $866.2K. EPS beat the consensus estimate of $-0.24 by $0.33.
How did Sanara MedTech Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.5% from $21.7M a year earlier.
Where can I find Sanara MedTech Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021715) and the 10-Q periodic report (0001493152-25-021894) directly on SEC EDGAR. The filing index links above go to sec.gov.